Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Summary
The global Medical Contrast Agent market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Lantheus Medical Imaging
Nanopet Pharma
CMC Contrast
Daiichi Sankyo
Subhra Pharma Private
Spago Nanomedical
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Other Applications
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Medical Contrast Agent Picture
1.1.2 Specifications
Table Product Specifications of Medical Contrast Agent
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Medical Contrast Agent
Table Global Medical Contrast Agent Market by Type, 2016-2026 (USD Million)
1.2.1.1 Barium-based Contrast Media
Table Barium-based Contrast Media Overview
1.2.1.2 Iodinated Contrast Media
Table Iodinated Contrast Media Overview
1.2.1.3 Gadolinium-based Contrast Media
Table Gadolinium-based Contrast Media Overview
1.2.1.4 Microbubble Contrast Media
Table Microbubble Contrast Media Overview
1.2.2 by Application
Table Application Segment of Medical Contrast Agent
Table Global Medical Contrast Agent Market by Application, 2016-2026 (USD Million)
1.2.2.1 Cardiovascular Disorders
Table Cardiovascular Disorders Overview
1.2.2.2 Neurological Disorders
Table Neurological Disorders Overview
1.2.2.3 Gastrointestinal Disorders
Table Gastrointestinal Disorders Overview
1.2.2.4 Cancer
Table Cancer Overview
1.2.2.5 Nephrological Disorders
Table Nephrological Disorders Overview
1.2.2.6 Musculoskeletal Disorders
Table Musculoskeletal Disorders Overview
1.2.2.7 Other Applications
Table Other Applications Overview
1.2.3 by Regions
Table Global Medical Contrast Agent Market by Region, 2016-2026 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Medical Contrast Agent
2.2 Upstream
Table Cost of Medical Contrast Agent
Figure Manufacturing Process of Medical Contrast Agent
2.3 Market
2.3.1 SWOT
Figure SWOT of Medical Contrast Agent
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Medical Contrast Agent
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Medical Contrast Agent
3.4 Market Entry
Table Market Entry of Medical Contrast Agent
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Barium-based Contrast Media Market, 2016-2020
Figure Barium-based Contrast Media Market Size and Growth, 2016-2020 (USD Million)
Figure Barium-based Contrast Media Market Size and Growth, 2016-2020 (in Volume)
Table Barium-based Contrast Media CAGR by Revenue and Volume, 2016-2020
4.1.2 Iodinated Contrast Media Market, 2016-2020
Figure Iodinated Contrast Media Market Size and Growth, 2016-2020 (USD Million)
Figure Iodinated Contrast Media Market Size and Growth, 2016-2020 (in Volume)
Table Iodinated Contrast Media CAGR by Revenue and Volume, 2016-2020
4.1.3 Gadolinium-based Contrast Media Market, 2016-2020
Figure Gadolinium-based Contrast Media Market Size and Growth, 2016-2020 (USD Million)
Figure Gadolinium-based Contrast Media Market Size and Growth, 2016-2020 (in Volume)
Table Gadolinium-based Contrast Media CAGR by Revenue and Volume, 2016-2020
4.1.4 Microbubble Contrast Media Market, 2016-2020
Figure Microbubble Contrast Media Market Size and Growth, 2016-2020 (USD Million)
Figure Microbubble Contrast Media Market Size and Growth, 2016-2020 (in Volume)
Table Microbubble Contrast Media CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 Barium-based Contrast Media Market Forecast, 2021-2026
Figure Barium-based Contrast Media Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Barium-based Contrast Media Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Barium-based Contrast Media CAGR by Revenue and Volume, 2016-2026
4.2.2 Iodinated Contrast Media Market Forecast, 2021-2026
Figure Iodinated Contrast Media Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Iodinated Contrast Media Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Iodinated Contrast Media CAGR by Revenue and Volume, 2016-2026
4.2.3 Gadolinium-based Contrast Media Market Forecast, 2021-2026
Figure Gadolinium-based Contrast Media Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Gadolinium-based Contrast Media Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Gadolinium-based Contrast Media CAGR by Revenue and Volume, 2016-2026
4.2.4 Microbubble Contrast Media Market Forecast, 2021-2026
Figure Microbubble Contrast Media Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Microbubble Contrast Media Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Microbubble Contrast Media CAGR by Revenue and Volume, 2016-2026
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Cardiovascular Disorders Market, 2016-2020
Figure Cardiovascular Disorders Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Cardiovascular Disorders CAGR by Revenue and Volume, 2016-2020
5.1.2 Neurological Disorders Market, 2016-2020
Figure Neurological Disorders Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Neurological Disorders CAGR by Revenue and Volume, 2016-2020
5.1.3 Gastrointestinal Disorders Market, 2016-2020
Figure Gastrointestinal Disorders Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Gastrointestinal Disorders CAGR by Revenue and Volume, 2016-2020
5.1.4 Cancer Market, 2016-2020
Figure Cancer Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Cancer CAGR by Revenue and Volume, 2016-2020
5.1.5 Nephrological Disorders Market, 2016-2020
Figure Nephrological Disorders Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Nephrological Disorders CAGR by Revenue and Volume, 2016-2020
5.1.6 Musculoskeletal Disorders Market, 2016-2020
Figure Musculoskeletal Disorders Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Musculoskeletal Disorders CAGR by Revenue and Volume, 2016-2020
5.1.7 Other Applications Market, 2016-2020
Figure Other Applications Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Other Applications CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Cardiovascular Disorders Market Forecast, 2021-2026
Figure Cardiovascular Disorders Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Cardiovascular Disorders Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Cardiovascular Disorders CAGR by Revenue and Volume, 2021-2026
5.2.2 Neurological Disorders Market Forecast, 2021-2026
Figure Neurological Disorders Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Neurological Disorders Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Neurological Disorders CAGR by Revenue and Volume, 2021-2026
5.2.3 Gastrointestinal Disorders Market Forecast, 2021-2026
Figure Gastrointestinal Disorders Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Gastrointestinal Disorders Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Gastrointestinal Disorders CAGR by Revenue and Volume, 2021-2026
5.2.4 Cancer Market Forecast, 2021-2026
Figure Cancer Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Cancer Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Cancer CAGR by Revenue and Volume, 2021-2026
5.2.5 Nephrological Disorders Market Forecast, 2021-2026
Figure Nephrological Disorders Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Nephrological Disorders Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Nephrological Disorders CAGR by Revenue and Volume, 2021-2026
5.2.6 Musculoskeletal Disorders Market Forecast, 2021-2026
Figure Musculoskeletal Disorders Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Musculoskeletal Disorders Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Musculoskeletal Disorders CAGR by Revenue and Volume, 2021-2026
5.2.7 Other Applications Market Forecast, 2021-2026
Figure Other Applications Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Other Applications Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Other Applications CAGR by Revenue and Volume, 2021-2026
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
7 Market Competitive
7.1 Global Market by Vendors
Table Global Medical Contrast Agent Market by Vendors, 2016-2020 (in Volume)
Table Global Medical Contrast Agent Market Share by Vendors, 2016-2020 (USD Million)
Table Global Medical Contrast Agent Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Medical Contrast Agent Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 GE Healthcare
Table GE Healthcare Profile List
Table Microecological Modulator Operating Data of GE Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Bayer
Table Bayer Profile List
Table Microecological Modulator Operating Data of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Bracco Imaging
Table Bracco Imaging Profile List
Table Microecological Modulator Operating Data of Bracco Imaging (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Guerbet Group
Table Guerbet Group Profile List
Table Microecological Modulator Operating Data of Guerbet Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Lantheus Medical Imaging
Table Lantheus Medical Imaging Profile List
Table Microecological Modulator Operating Data of Lantheus Medical Imaging (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Nanopet Pharma
Table Nanopet Pharma Profile List
Table Microecological Modulator Operating Data of Nanopet Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 CMC Contrast
Table CMC Contrast Profile List
Table Microecological Modulator Operating Data of CMC Contrast (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Daiichi Sankyo
Table Daiichi Sankyo Profile List
Table Microecological Modulator Operating Data of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Subhra Pharma Private
Table Subhra Pharma Private Profile List
Table Microecological Modulator Operating Data of Subhra Pharma Private (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Spago Nanomedical
Table Spago Nanomedical Profile List
Table Microecological Modulator Operating Data of Spago Nanomedical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Price : US$ 3,500 |
Date : Apr 2024 |
Category : Services |
Pages : 120 |